Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Trial of SHR-4658 in Healthy Volunteers or Volunteers With Elevated Blood Pressure
Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd
Summary
This is a clinical study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamic and immunogenicity of single subcutaneous injection of SHR-4658 in healthy volunteers and volunteers with elevated blood pressure.
Official title: A Double-Blind, Randomized, Dose-Escalating Phase I Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single-Dose SHR-4658 in Healthy Volunteers or Volunteers With Elevated Blood Pressure
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
48
Start Date
2025-11
Completion Date
2026-07
Last Updated
2025-11-17
Healthy Volunteers
Yes
Conditions
Interventions
SHR-4658 Injection.
SHR-4658 injection.
SHR-4658 Placebo Injection
SHR-4658 placebo injection.
Locations (1)
Beijing Anzhen Hospital Capital Medical University
Beijing, Beijing Municipality, China